ANTI-INFLAMMATORY COMPOUND, AND PREPARATION AND USE THEREOF
申请人:VivaVision Biotech, Inc.
公开号:US20200377460A1
公开(公告)日:2020-12-03
The present invention provides an anti-inflammatory compound, which is a compound having a structure (I) as shown below:
The compound is a target that is important for autoimmune activation, and that has strong inhibitory effect on PDE4 and penetrates the skin easily, and is a new type anti-inflammatory compound that is easily degraded.
Heterocyclic Lithium Amides as Chiral Ligands for an Enantioselective Hydroxyalkylation with <i>n</i>-BuLi
作者:Nicolas Duguet、Sylvain M. Petit、Philippe Marchand、Anne Harrison-Marchand、Jacques Maddaluno
DOI:10.1021/jo8005396
日期:2008.7.1
Chiralheterocyclic structures based on 3-aminopyrrolidines (3APs), 3-aminotetrahydrothiophens (3ATTs), and 3-aminotetrahydrofurans (3ATFs) have been synthesized. The corresponding lithium amides have been evaluated as chiralligands in the condensation of n-BuLi on o-tolualdehyde. The returned levels of induction were in the 46−80% ee range. The cheap and easily prepared 3ATFLi’s turned out to be